Progenics, a biopharmaceutical company focused on innovative therapeutics for patients suffering from cancer and related conditions, has made the decision to outsource production, and as a result now has an inventory of surplus bioprocessing equipment. This project represents a great opportunity for EquipNet customers to capitalize on our client’s surplus inventory, and purchase quality equipment, with very low run-times, for a greatly discounted price.
Currently this inventory features assets from the following renowned OEMs:
• And more!
All equipment is available for inspection. If you have questions, or would like to schedule an inspection, contact an EquipNet Sales Representative today!